Mann M - Search Results

1

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.

Cortez V, Mann M, Tekmal S, Suzuki T, Miyata N, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Vadlamudi RK. Cortez V, et al. Among authors: mann m. Breast Cancer Res. 2012 Jul 19;14(4):R108. doi: 10.1186/bcr3229. Breast Cancer Res. 2012. PMID: 22812534 Free PMC article.

2

Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Cortez V, Mann M, Brann DW, Vadlamudi RK. Cortez V, et al. Among authors: mann m. Minerva Ginecol. 2010 Dec;62(6):573-83. Minerva Ginecol. 2010. PMID: 21079578 Free PMC article. Review.

3

Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy.

Mann M, Cortez V, Vadlamudi RK. Mann M, et al. Cancers (Basel). 2011 Mar 29;3(3):1691-707. doi: 10.3390/cancers3021691. Cancers (Basel). 2011. PMID: 21814622 Free PMC article.

4

Emerging significance of estrogen cancer coregulator signaling in breast cancer.

Mann M, Krishnan S, Vadlamudi RK. Mann M, et al. Minerva Ginecol. 2012 Feb;64(1):75-88. Minerva Ginecol. 2012. PMID: 22334233 Review.

5

PELP1 oncogenic functions involve CARM1 regulation.

Mann M, Cortez V, Vadlamudi R. Mann M, et al. Carcinogenesis. 2013 Jul;34(7):1468-75. doi: 10.1093/carcin/bgt091. Epub 2013 Mar 13. Carcinogenesis. 2013. PMID: 23486015 Free PMC article.

6

PELP1 oncogenic functions involve alternative splicing via PRMT6.

Mann M, Zou Y, Chen Y, Brann D, Vadlamudi R. Mann M, et al. Mol Oncol. 2014 Mar;8(2):389-400. doi: 10.1016/j.molonc.2013.12.012. Epub 2013 Dec 30. Mol Oncol. 2014. PMID: 24447537 Free PMC article.

7

Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response.

Nair BC, Krishnan SR, Sareddy GR, Mann M, Xu B, Natarajan M, Hasty P, Brann D, Tekmal RR, Vadlamudi RK. Nair BC, et al. Among authors: mann m. Cell Death Differ. 2014 Sep;21(9):1409-18. doi: 10.1038/cdd.2014.55. Epub 2014 May 2. Cell Death Differ. 2014. PMID: 24786831 Free PMC article.

8

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers.

Raj GV, Sareddy GR, Ma S, Lee TK, Viswanadhapalli S, Li R, Liu X, Murakami S, Chen CC, Lee WR, Mann M, Krishnan SR, Manandhar B, Gonugunta VK, Strand D, Tekmal RR, Ahn JM, Vadlamudi RK. Raj GV, et al. Among authors: mann m. Elife. 2017 Aug 8;6:e26857. doi: 10.7554/eLife.26857. Elife. 2017. PMID: 28786813 Free PMC article.

9

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.

Altwegg KA, Viswanadhapalli S, Mann M, Chakravarty D, Krishnan S, Liu Z, Liu J, Pratap UP, Ebrahimi B, Sanchez JR, Li X, Ma S, Park BH, Santhamma B, Chen Y, Lai Z, Raj GV, Yuan Y, Zhou D, Sareddy GR, Tekmal RR, McHardy S, Huang TH, Rao MK, Vankayalapati H, Vadlamudi RK. Altwegg KA, et al. Among authors: mann m. Cancer Res. 2022 Oct 17;82(20):3830-3844. doi: 10.1158/0008-5472.CAN-22-0698. Cancer Res. 2022. PMID: 35950923 Free PMC article.

10

A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription.

Jiao X, Di Sante G, Casimiro MC, Tantos A, Ashton AW, Li Z, Quach Y, Bhargava D, Di Rocco A, Pupo C, Crosariol M, Lazar T, Tompa P, Wang C, Yu Z, Zhang Z, Aldaaysi K, Vadlamudi R, Mann M, Skordalakes E, Kossenkov A, Du Y, Pestell RG. Jiao X, et al. Among authors: mann m. Oncogenesis. 2024 Jan 8;13(1):4. doi: 10.1038/s41389-023-00502-1. Oncogenesis. 2024. PMID: 38191593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,270 results

Search Page